Treatment of myofascial trigger points in XXXX with @entity1118 : a randomized, controlled trial.

@entity1 @entity1118 @entity158 @entity11452
BACKGROUND: Shoulder @entity158 is a common musculoskeletal problem that is often chronic or recurrent. Myofascial trigger points (MTrPs) cause @entity158 and are prevalent in @entity1 with @entity158 . However, few studies have focused on @entity11452 therapy. The aim of this study was to assess the effectiveness of multimodal treatment of MTrPs in @entity1 with @entity1118 . METHODS: A single-assessor, blinded, randomized, controlled trial was conducted. The intervention group received comprehensive treatment once weekly consisting of manual compression of the MTrPs, manual stretching of the muscles and intermittent cold application with stretching. @entity1 were instructed to perform muscle-stretching and relaxation exercises at home and received ergonomic recommendations and advice to assume and maintain good posture. The control group remained on the waiting list for 3 months. The Disabilities of Arm, Shoulder and Hand (DASH) questionnaire score (primary outcome), Visual Analogue Scale for @entity158 (VAS-P), Global Perceived Effect (GPE) scale and the number of muscles with MTrPs were assessed at 6 and 12 weeks in the intervention group and compared with those of a control group. RESULTS: Compared with the control group, the intervention group showed significant improvement (P < 0.05) on the DASH after 12 weeks (mean difference, 7.7; 95% confidence interval (95% CI), 1.2 to 14.2), on the VAS-P1 for current @entity158 (mean difference, 13.8; 95% CI, 2.6 to 25.0), on the VAS-P2 for @entity158 in the past 7 days (mean difference, 10.2; 95% CI, 0.7 to 19.7) and VAS-P3 most severe @entity158 in the past 7 days (mean difference, 13.8; 95% CI, 0.8 to 28.4). After 12 weeks, 55% of the @entity1 in the intervention group reported improvement (from slightly improved to completely recovered) versus 14% in the control group. The mean number of muscles with active MTrPs decreased in the intervention group compared with the control group (mean difference, 2.7; 95% CI, 1.2 to 4.2). CONCLUSIONS: The results of this study show that 12-week comprehensive treatment of MTrPs in shoulder muscles reduces the number of muscles with active MTrPs and is effective in reducing symptoms and improving shoulder function in @entity1 with @entity1118 . TRIAL REGISTRATION NUMBER: ISRCTN: ISRCTN75722066.
